Skip to main content
profile image
Selected Works of Brian D. Piening, PhD
Article
Tumor antigen expression and survival of patients with previously treated advanced non-small cell lung cancer (NSCLC) receiving viagenpumatucel-L (HS-110) plus nivolumab.
Journal of Clinical Oncology (2020)
  • Daniel Morgensztern, Washington University in St. Louis
  • Saiama Naheed Waqar, Washington University in St. Louis
  • Lyudmila Bazhenova, University of California, San Diego
  • Lori McDermott, Durham University
  • Jeff Hutchins, Durham University
  • David H Taylor, Heat Biologics, Morrisville, NC;
  • Fred L Robinson, Providence Portland Medical Center
  • Alexa K Dowdell, Providence Portland Medical Center
  • Brian D. Piening, Earle A. Chiles Research Institute at Robert W. Franz Cancer Center, Providence Cancer Institute, Portland, OR;
  • Wael A Harb, Horizon Oncology Research, LLC, Lafayette, IN;
  • Nathan A Pennell, Cleveland Clinic
  • Roger B Cohen, University of Pennsylvania
Link
Disciplines
Publication Date
May 25, 2020
DOI
10.1200/JCO.2020.38.15_SUPPL.9546
Citation Information
Daniel Morgensztern, Saiama Naheed Waqar, Lyudmila Bazhenova, Lori McDermott, et al.. "Tumor antigen expression and survival of patients with previously treated advanced non-small cell lung cancer (NSCLC) receiving viagenpumatucel-L (HS-110) plus nivolumab." Journal of Clinical Oncology Vol. 38 (2020) p. 9546 - 9546
Available at: http://works.bepress.com/brian-piening/14/